Clinical trials: Distal Subungual Onychomycosis
Distal Lateral Subungual Onychomycosis, Onychomycosis
Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis
This is a Pre-IDE, prospective, multicenter, randomized, parallel-group, double-blind, vehicle- controlled study to evaluate safety and effectiveness of Nail Genesis DLSO Product for the treatment of DLSO compared with vehicle in…
- Trial name
- NCT06074315
- Testing
- Nail Genesis DLSO Product, Nail Genesis DLSO Product (vehicle only)
- Where
- 10 sites in United States
- Volunteers
- 338 people
- Sponsor
- Nail Genesis LLC
Distal Subungual Onychomycosis, Fungal Infection
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail
This study will be a multicenter, international, randomized, vehicle-controlled, parallel-group, double-blinded study. Subjects who are eligible to participate with a confirmed diagnosis of Distal Subungual onychomycosis (DSO) of…
- Conditions
- Distal Subungual Onychomycosis, Fungal Infection, Fungus, Nail
- Trial name
- NCT04188574
- Testing
- BB2603-1, BB2603-3, BB2603-10
- Where
- 20 sites in Czechia, Germany and 1 more
- Volunteers
- 111 people
- Sponsor
- Blueberry Therapeutics
Distal Subungual Onychomycosis
A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
The primary objective of this study is to evaluate the efficacy of topical MOB015B in patients with mild to moderate distal subungual onychomycosis (DSO).
- Trial name
- NCT02859519
- Testing
- MOB015B, MOB015B Vehicle
- Where
- 10 sites in United States, Canada
- Volunteers
- 365 people
- Sponsor
- Moberg Pharma AB
Distal Subungual Onychomycosis
Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
The primary objective of this study is to evaluate the efficacy of topical MOB015B in patients with mild to moderate distal subungual onychomycosis (DSO).
- Trial name
- NCT02866032
- Testing
- MOB015B, Ciclopirox 80 mg/g
- Where
- 3 sites in Germany, Poland and 1 more
- Volunteers
- 452 people
- Sponsor
- Moberg Pharma AB
Distal, Subungual Onychomycosis
Study of Different Doses of a Novel Treatment for Onychomycosis
The purpose of the study is to determine the safety and efficacy of 2.5%, 5.0%, and 7.5% AN2690 Solutions compared to the vehicle alone in the treatment of distal, subungual onychomycosis of the great target toenail.
- Trial name
- NCT00679965
- Testing
- AN2690, 2.5%, AN2690, 5%, AN2690, 7.5%
- Where
- 9 sites in Mexico
- Volunteers
- 159 people
- Sponsor
- Pfizer
Distal, Subungual Onychomycosis
Study of Different Doses of a Novel Treatment for Onychomycosis
The purpose of the study is to determine the safety and efficacy of 2.5%, 5.0%, and 7.5% AN2690 Solutions compared to the vehicle alone in the treatment of distal, subungual onychomycosis of the great target toenail.
- Trial name
- NCT00679770
- Testing
- AN2690, 2.5%, AN2690, 5%, AN2690, 7.5%
- Where
- 4 sites in United States
- Volunteers
- 28 people
- Sponsor
- Pfizer
Distal and Lateral Subungual Onychomycosis
Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis
The purpose of this study is to determine the safety and efficacy of a topical antifungal formulation, Luliconazole Solution, 10%, in the treatment of adults with onychomycosis of the toenails.
- Trial name
- SOLUTION (NCT01431820)
- Testing
- Luliconazole Solution, 10%, Vehicle Solution
- Where
- 28 sites in United States
- Volunteers
- 334 people
- Sponsor
- Topica Pharmaceuticals
Distal Subungual Onychomycosis
An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
Assess efficacy and safety of topical MOB015B, applied daily during 48 weeks, in adults with fungal nail infection.
- Trial name
- NCT01814020
- Testing
- MOB015B
- Where
- Sweden
- Sponsor
- Moberg Pharma AB
Distal Subungual Onychomycosis
A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis
The purpose of this study is to determine if a local treatment is effective for the treatment of toenail fungus (distal subungual onychomycosis).
- Trial name
- NCT01093118
- Testing
- TMI-358, MMI-467
- Where
- 7 sites in United States
- Volunteers
- 120 people
- Sponsor
- Talima Therapeutics, Inc.